当前位置: X-MOL 学术ACS Sens. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
AT1R-Specific Ligand Angiotensin II as a Novel SPECT Agent for Hepatocellular Carcinoma Diagnosis
ACS Sensors ( IF 8.9 ) Pub Date : 2020-11-24 , DOI: 10.1021/acssensors.0c02180
Yuanbiao Tu 1, 2 , Zicun Liu 1 , Fang Wang 1 , Peifei Liu 1 , Ji Tao 1 , Changsheng Li 1 , Zhihao Han 1 , Zhaolun Li 1 , Yi Ma 1 , Yueqing Gu 1
Affiliation  

Hepatocellular carcinoma (HCC) is characterized by a high mortality and early diagnosis and treatment are critically needed. Ang II type 1 receptor (AT1R) has recently emerged as a potential molecular target for cancer diagnosis and intervention. Here, we labeled angiotensin II (Ang II), an AT1R ligand that is overexpressed in various solid cancers, with the near-infrared fluorescent dye, MPA, and radionuclide technetium-99m, and evaluated its capacity for HCC detection. These analyses were done in vitro using HepG2 (AT1R-positive) and BxPC3 (AT1R-negative) cell lines, and in vivo using a subcutaneous and orthotopic xenograft mouse model by fluorescence and SPECT imaging. Both Ang II-PEG4-MPA- and [99mTc]Tc-HYNIC-PEG4-Ang II-bound AT1R exhibited a high affinity in vitro and [99mTc]Tc-HYNIC-PEG4-Ang II displayed an acceptable level of in vitro stability in rat plasma and whole blood. In vivo imaging revealed excellent specific tumor-targeting in HepG2 mouse xenografts models. In vitro and in vivo competition experiments revealed specific Ang II-PEG4-MPA and [99mTc]Tc-HYNIC-PEG4-Ang II uptake by HepG2 cells and tumors. Altogether, AT1R-positive tumors were successfully detected via fluorescence and SPECT imaging using Ang II-PEG4-MPA and [99mTc]Tc-HYNIC-PEG4-Ang II, respectively. Given their superior targeting capacity, Ang II-PEG4-MPA and [99mTc]Tc-HYNIC-PEG4-Ang II are promising tools for HCC detection and warrant clinical translation.

中文翻译:

AT1R特异的配体血管紧张素II作为肝细胞癌诊断的新型SPECT剂

肝细胞癌(HCC)的特点是死亡率高,因此迫切需要早期诊断和治疗。Ang II 1型受体(AT1R)最近已成为癌症诊断和干预的潜在分子靶标。在这里,我们用近红外荧光染料,MPA和放射性核素tech 99m标记了在多种实体癌中过表达的AT1R配体血管紧张素II(Ang II),并评估了其检测HCC的能力。这些分析是在体外使用HepG2(AT1R阳性)和BxPC3(AT1R阴性)细胞系进行的,在体内使用皮下和原位异种移植小鼠模型通过荧光和SPECT成像进行的。Ang II-PEG 4 -MPA-和[ 99m Tc] Tc-HYNIC-PEG 4-Ang II结合的AT1R在体外表现出高亲和力,[ 99m Tc] Tc-HYNIC-PEG 4 -Ang II在大鼠血浆和全血中显示出可接受的体外稳定性水平。体内成像显示在HepG2小鼠异种移植模型中出色的特异性肿瘤靶向。体外和体内竞争实验表明,HepG2细胞和肿瘤可摄取特定的Ang II-PEG 4 -MPA和[ 99m Tc] Tc-HYNIC-PEG 4 -Ang II。总之,分别使用Ang II-PEG 4 -MPA和[ 99m Tc] Tc-HYNIC-PEG 4 -Ang II通过荧光和SPECT成像成功检测到了AT1R阳性肿瘤。鉴于其卓越的靶向能力,Ang II-PEG 4-MPA和[ 99m Tc] Tc-HYNIC-PEG 4 -Ang II是用于HCC检测的有前途的工具,值得临床翻译。
更新日期:2020-12-24
down
wechat
bug